JP2020509061A5 - - Google Patents

Download PDF

Info

Publication number
JP2020509061A5
JP2020509061A5 JP2019548059A JP2019548059A JP2020509061A5 JP 2020509061 A5 JP2020509061 A5 JP 2020509061A5 JP 2019548059 A JP2019548059 A JP 2019548059A JP 2019548059 A JP2019548059 A JP 2019548059A JP 2020509061 A5 JP2020509061 A5 JP 2020509061A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019548059A
Other languages
English (en)
Japanese (ja)
Other versions
JP6965362B2 (ja
JP2020509061A (ja
Filing date
Publication date
Priority claimed from CN201710115604.4A external-priority patent/CN106860855B/zh
Priority claimed from CN201710677602.4A external-priority patent/CN109384830B/zh
Application filed filed Critical
Priority claimed from PCT/CN2018/077492 external-priority patent/WO2018157807A1/zh
Publication of JP2020509061A publication Critical patent/JP2020509061A/ja
Publication of JP2020509061A5 publication Critical patent/JP2020509061A5/ja
Application granted granted Critical
Publication of JP6965362B2 publication Critical patent/JP6965362B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019548059A 2017-03-01 2018-02-28 ポリペプチド、ポリペプチド断片及びその誘導体、並びに応用 Active JP6965362B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201710115604.4 2017-03-01
CN201710115604.4A CN106860855B (zh) 2017-03-01 2017-03-01 多肽及多肽衍生物在预防和治疗纤维化疾病中的应用
CN201710677602.4A CN109384830B (zh) 2017-08-09 2017-08-09 多肽、多肽片段及其衍生物在防治纤维化疾病中的应用
CN201710677602.4 2017-08-09
PCT/CN2018/077492 WO2018157807A1 (zh) 2017-03-01 2018-02-28 多肽、多肽片段及其衍生物与应用

Publications (3)

Publication Number Publication Date
JP2020509061A JP2020509061A (ja) 2020-03-26
JP2020509061A5 true JP2020509061A5 (enExample) 2020-07-09
JP6965362B2 JP6965362B2 (ja) 2021-11-10

Family

ID=63369746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019548059A Active JP6965362B2 (ja) 2017-03-01 2018-02-28 ポリペプチド、ポリペプチド断片及びその誘導体、並びに応用

Country Status (9)

Country Link
US (2) US12011475B2 (enExample)
EP (1) EP3590527A4 (enExample)
JP (1) JP6965362B2 (enExample)
KR (1) KR102368159B1 (enExample)
AU (1) AU2018227737B2 (enExample)
CA (1) CA3054839C (enExample)
IL (1) IL268971B2 (enExample)
SG (1) SG11201907914QA (enExample)
WO (1) WO2018157807A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3368512T3 (pl) * 2015-10-27 2024-05-27 Taipei Medical University Pochodne indoliny do leczenia i/albo zapobiegania chorobie zwłóknieniowej
CN112386678B (zh) * 2019-08-13 2023-07-07 成都惠泰生物医药有限公司 多肽或其衍生物的应用
US20230125173A1 (en) * 2021-08-11 2023-04-27 HCW Biologics, Inc. Multi-chain chimeric polypeptides and use thereof in the treatment of liver diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9509957D0 (en) 1995-05-17 1995-07-12 Khalil Nasreen Post-translational activation of tgf-›1 involving the tsp-1 receptor cd36
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
SI1105409T1 (sl) 1999-05-17 2006-06-30 Conjuchem Inc Zascita endogenih peptidov pred peptidazno ucinkovitostjo s konjugacijo na krvne komponente
JP2005528082A (ja) 2001-12-18 2005-09-22 モンドバイオテック・ラボラトリーズ・アンスタルト 間質性肺疾患の治療を向上させるためのインターフェロンγ又はパーフェニドンと分子診断薬との新規医薬組成物
CA2699100A1 (en) 2007-09-11 2009-04-02 Dorian Bevec Use of a peptide as a therapeutic agent
WO2009043525A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of the combination of gluten exorphin c and cd36 as a therapeutic agent
JP2014506117A (ja) * 2010-11-24 2014-03-13 エフ.ホフマン−ラ ロシュ アーゲー 軽度の炎症を検出するための方法
EP3954704A1 (en) 2011-06-03 2022-02-16 XOMA Technology Ltd. Antibodies specific for tgf-beta
WO2016054114A1 (en) 2014-09-29 2016-04-07 The Regents Of The University Of California Compositions for expanding regulatory t cells (treg), and treating autoimmune and inflammatory diseases and conditions
CN104313028A (zh) 2014-09-30 2015-01-28 北京生科东方科技有限公司 抗类风湿关节炎的小肽基因及其生产方法
CN105061600A (zh) 2015-09-05 2015-11-18 苏州普罗达生物科技有限公司 类风湿因子IgA抑制多肽及其应用
CN106860855B (zh) * 2017-03-01 2021-06-11 成都惠泰生物医药有限公司 多肽及多肽衍生物在预防和治疗纤维化疾病中的应用

Similar Documents

Publication Publication Date Title
JP2019164961A5 (enExample)
JP2019523723A5 (enExample)
JP2017142496A5 (enExample)
JP2017107167A5 (enExample)
JP2020183924A5 (enExample)
JP2018186811A5 (enExample)
JP2021503553A5 (enExample)
JP2020175021A5 (enExample)
JP2017179103A5 (enExample)
JP2019210167A5 (enExample)
JP2021512134A5 (enExample)
JP2018144050A5 (enExample)
JP2019526558A5 (enExample)
JP2020049413A5 (enExample)
JP2020031580A5 (enExample)
JP2020043052A5 (enExample)
JP2020180208A5 (enExample)
JP2019218238A5 (enExample)
JP2019073673A5 (enExample)
JP2019106905A5 (enExample)
JP2019026656A5 (enExample)
JP2018126872A5 (enExample)
JP2020147467A5 (enExample)
JP2020135963A5 (enExample)
JP2020524126A5 (enExample)